Abstract

ObjectiveCervical intraepithelial neoplasia grade 3 (CIN3), the immediate cervical cancer precursor, is a target of cervical cancer prevention. However, less than half of CIN3s will progress to cancer. Routine treatment of all CIN3s and the majority of CIN2s may lead to overtreatment of many lesions that would not progress. To improve our understanding of CIN3 natural history, we performed a detailed characterization of CIN3 heterogeneity in a large referral population in the US.MethodsWe examined 309 CIN3 cases in the SUCCEED, a large population-based study of women with abnormal cervical cancer screening results. Histology information for 12 individual loop electrosurgical excision procedure (LEEP) segments was evaluated for each woman. We performed case-case comparisons of CIN3s to analyze determinants of heterogeneity and screening test performance.ResultsCIN3 cases varied substantially by size (1–10 LEEP segments) and by presentation with concomitant CIN2 and CIN1. All grades of CINs were equally distributed over the cervical surface. In half of the women, CIN3 lesions were found as multiple distinct lesions on the cervix. Women with large and solitary CIN3 lesions were more likely to be older, have longer sexual activity span, and have fewer multiple high risk HPV infections. Screening frequency, but not HPV16 positivity, was an important predictor of CIN3 size. Large CIN3 lesions were also characterized by high-grade clinical test results.ConclusionsWe demonstrate substantial heterogeneity in clinical and pathological presentation of CIN3 in a US population. Time since sexual debut and participation in screening were predictors of CIN3 size. We did not observe a preferential site of CIN3 on the cervical surface that could serve as a target for cervical biopsy. Cervical cancer screening procedures were more likely to detect larger CIN3s, suggesting that CIN3s detected by multiple independent diagnostic tests may represent cases with increased risk of invasion.

Highlights

  • The natural history of human papillomavirus (HPV) leading to invasive cervical cancer is well established [1]

  • We did not observe a preferential site of cervical intraepithelial neoplasia grade 3 (CIN3) on the cervical surface that could serve as a target for cervical biopsy

  • Cervical cancer screening procedures were more likely to detect larger CIN3s, suggesting that CIN3s detected by multiple independent diagnostic tests may represent cases with increased risk of invasion

Read more

Summary

Introduction

The natural history of human papillomavirus (HPV) leading to invasive cervical cancer is well established [1]. Few infections persist and progress to pre-cancer, diagnosed histologically as cervical intraepithelial neoplasia grade 3 (CIN3) [2]. Primary prevention by HPV vaccination or secondary prevention by screening for and removing a cancer precursor before invasion occurs are currently the basis for cervical cancer prevention [2]. A confirmed CIN3 is typically treated by the loop electrosurgical excision procedure (LEEP) according to American Society for Colposcopy and Cervical Pathology (ASCCP) guidelines [3]. Only 30– 50% of advanced CIN3 lesions progress to cancer [4,5], indicating that there is a variability of risk of invasion to cervical cancer within a group collectively defined as CIN3 [6]. Overtreatment with LEEP may put women at unnecessary risk of side effects such as bleeding and infection [7] as well as potential negative impact on reproductive outcomes for young women [8]

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call